A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma
Clinical trial NCT03711279 · TERMINATED
Trial details
- NCT number
- NCT03711279
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-22
- Primary completion
- 2021-06-21
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.